Increased AUC & C
max w/ P-gp inhibitors eg, amiodarone, carvedilol, clarithromycin, cobicistat, darunavir, dronedarone, erythromycin, indinavir, itraconazole, ketoconazole, lapatinib, lopinavir, propafenone, quinidine, ranolazine, ritonavir, saquinavir, telaprevir, tipranavir, verapamil. Decreased exposure w/ P-gp inducers eg, carbamazepine, phenytoin, St. John's wort. Increased exposure w/ strong BCRP inhibitors eg, curcumin, cyclosporine.